Microbiology-driven De-escalation

Microbiology-Driven De-Escalation is a clinical decision-making strategy in antimicrobial stewardship wherein the refinement of empirical therapy is specifically guided by definitive microbiological evidence, such as pathogen identification and antimicrobial susceptibility testing, to narrow spectrum, optimize efficacy, and minimize resistance selection pressure.

5

Publications

212

Citations

27

Authors

18

Institutions

Publications per year

2017–2026

1

Publications

5

1–5 of 5

Authors

27

  1. WK
    Wen‐Chien Ko

    National Cheng Kung University, Taiwan

    2 publications · 60 citations

    2

    h-index

  2. CL
    Ching‐Chi Lee

    National Cheng Kung University Hospital, Taiwan

    2 publications · 60 citations

    2

    h-index

  3. MH
    Ming‐Yuan Hong

    National Cheng Kung University Hospital, Taiwan

    2 publications · 60 citations

    2

    h-index

  4. PH
    Pau Herrero

    Imperial College London, United Kingdom

    1 publications · 63 citations

    1

    h-index

  5. LJ
    Linda Johnson

    Lund University, Sweden

    1 publications · 33 citations

    1

    h-index

1–5 of 27

Venues

  1. 1

    h-index

  2. BMC Medicine

    1 publications · 63 citations

    1

    h-index

  3. International Journal of Antimicrobial Agents

    1 publications · 22 citations

    1

    h-index

  4. Journal of Clinical Microbiology

    JCM · 1 publications · 56 citations

    1

    h-index

  5. 1

    h-index

1–5